Vir Biotechnology, Inc. EPS (Earnings per Share) 2017–2025
Vir Biotechnology, Inc. reported $-3.16 of earnings per share for fiscal 2025. That was 17.5% higher than fiscal 2024. Compared with fiscal 2020, the change was -25.9%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-3.16 | +17.5% |
| FY 2024 | $-3.83 | +16.6% |
| FY 2023 | $-4.59 | -219.8% |
| FY 2022 | $3.83 | -3.3% |
| FY 2021 | $3.96 | +257.8% |
| FY 2020 | $-2.51 | +56.4% |
| FY 2019 | $-5.76 | — |
| FY 2018 | $0.00 | — |
| FY 2017 | $0.00 | — |
Source: Vir Biotechnology, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open VIR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Vir Biotechnology, Inc. reported $-3.16 of earnings per share for fiscal 2025. That was 17.5% higher than fiscal 2024. Compared with fiscal 2020, the change was -25.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Vir Biotechnology, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVir Biotechnology, Inc. — frequently asked questions
What is Vir Biotechnology, Inc.'s earnings per share?
Vir Biotechnology, Inc. (VIR) reported earnings per share of $-3.16 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Vir Biotechnology, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.